# Chapter 4: Claude Says

## LLM Details

**Model used:** Claude Sonnet (claude.ai, free tier)  
**Date of debate:** March 2026  
**Note:** All responses were elicited using the free-tier web interface at claude.ai. No system prompt modifications were applied. Each argument was presented as a standalone prompt in a fresh conversation to avoid contextual carry-over between arguments.

---

## Overview

This chapter records a debate with Claude across the four ethical conflict points identified in Chapter 3. Each argument was prompted separately, asking for at least two distinct positions with reasoning. Claude's responses are reproduced in full and then examined critically. Where the reasoning is weak, incomplete, or logically flawed, this is noted directly.

---

## Argument 1: Sensitivity Optimisation vs Alert Fatigue — Should the Threshold Be Raised?

### Prompt

> *"In a deployed AI sepsis detection system, the alert threshold is set at Score ≥ 5, optimising for high sensitivity (86%) but producing a positive predictive value of only 33.8%. This means roughly two thirds of alerts are false positives. From an ethical standpoint, should the threshold be raised to reduce alert fatigue, even if some sepsis cases are missed? Give me at least two distinct actions or non-actions you would recommend, and explain the reasoning behind each. Please keep your response to 300–400 words total."*

### Claude's Response

> **Recommendation 1: Do not raise the threshold unilaterally — instead, stratify alerts by context.**
> Rather than a blunt threshold increase, the system should implement tiered alerting based on clinical setting. An ICU team managing critically ill patients can act on lower-confidence alerts; a general ward with stretched staffing cannot. A uniform Score ≥ 5 rule ignores this reality. Deploying a higher threshold (say, ≥ 7) only in lower-acuity settings preserves sensitivity where it matters most while reducing noise where alert fatigue is most damaging. The ethical justification is proportionality — the same decision rule should not apply uniformly when the consequences of both false positives and false negatives differ substantially across environments.
>
> **Recommendation 2: Measure and act on alert fatigue empirically before changing the threshold at all.**
> Before adjusting the threshold, the deploying organisation should audit clinician override rates, response times, and documented sepsis cases that were acted upon versus ignored. If clinicians are already dismissing 70% of alerts reflexively, the current threshold may already be functionally equivalent to a higher one — just with hidden harm. Raising the threshold without this data risks enshrining a guess as policy. The ethical principle here is epistemic humility: when a decision affects patient outcomes, it should be grounded in local evidence, not modelling assumptions alone.
>
> **Underlying principle:** Optimising a threshold is not purely a statistical exercise — it is a values-laden decision about whose risk is acceptable. That decision should involve clinicians, patients, and ethicists, not only the AI development team.

> 📸 *[Insert screenshot: Argument 1 prompt and response]*

### Analysis

Recommendation 2 is the stronger of the two. Grounding threshold decisions in local audit data before making any change is reasonable, and the point about clinicians already dismissing most alerts reflexively is a real phenomenon worth taking seriously.

Recommendation 1 is where the reasoning breaks down. Claude suggests raising the threshold on general wards to reduce alert burden, framing this as proportionality. The problem is that a patient on a general ward with a score of 6 has the same physiological state as an ICU patient with a score of 6. Under this proposal, only the ICU patient receives an alert. That is not proportionality, it is a two tier detection standard based on bed location rather than clinical need. General ward patients also tend to have less continuous monitoring than ICU patients, which makes missing a deteriorating sepsis case there arguably more dangerous. The logic runs in the opposite direction to what Claude claims.

The closing point about involving clinicians, patients and ethicists sounds reasonable but is doing no real argumentative work. Claude offers no mechanism for how that process runs, who has final authority, or what happens when clinical preference conflicts with outcome data.

**Logical error:** Recommendation 1 treats ward type as a reliable proxy for the consequences of false positives and false negatives. It is not, and the reasoning produces exactly the inequity it claims to avoid.

---

## Argument 2: Transparency vs Proprietary Opacity — Is the Responsibility Gap Defensible?

### Prompt

> *"The Epic Sepsis Model generates a risk score but does not expose its internal reasoning to clinicians. Clinicians remain legally and morally accountable for decisions made in response to AI alerts, yet cannot fully explain the basis of those alerts. Is this ethically acceptable? Give me at least two distinct positions — one defending the current opaque design and one arguing for mandatory explainability — with the reasoning behind each. Please keep your response to 300–400 words total."*

### Claude's Response

> **Position 1: Opacity is defensible — clinicians are not obligated to understand the tool's internals.**
> A clinician using an opaque sepsis alert is in a structurally similar position to one interpreting a lab result: they do not need to understand the chemistry of a troponin assay to act appropriately on an elevated reading. What matters is that the tool's population-level performance is validated, communicated, and understood. If clinicians know the score has 86% sensitivity and a 33.8% PPV, they have actionable calibration information. Demanding full mechanistic transparency may actually be counterproductive — complex feature interactions in ML models can produce explanations that are technically accurate but cognitively misleading.
>
> **Position 2: Opacity is ethically unacceptable when accountability remains with the clinician.**
> The asymmetry is genuinely troubling. Clinicians bear full legal and moral responsibility for outcomes, yet are denied access to the reasoning that generated the alert they must respond to. This is not analogous to a lab test — a troponin value is a direct measurement of a biological quantity, whereas an AI score is an inference built on weighted feature combinations that may encode biases or training artefacts invisible to the end user. Meaningful accountability requires meaningful access. Explainability shifts the epistemic relationship from passive alert-reception to genuine clinical reasoning.
>
> **Unresolved tension:** Both positions share a concern for patient safety but disagree on whether opacity or false explainability poses the greater risk. That disagreement demands empirical study of how clinicians actually use explanations when provided.

> 📸 *[Insert screenshot: Argument 2 prompt and response]*

### Analysis

Position 2 correctly identifies the core problem. Clinicians are held fully accountable for outcomes while being denied access to the reasoning behind the alerts they act on. That asymmetry is the central ethical issue with the ESM, and Claude names it clearly.

Position 1 is where the reasoning fails, and the failure is specific. Claude argues that using an opaque sepsis alert is structurally similar to interpreting a lab result: a clinician does not need to understand the chemistry of a troponin assay to act on an elevated reading. This analogy does not hold. A troponin result is a direct measurement of a biological quantity with known, traceable error sources. If a troponin is wrong, the cause can be identified: reagent failure, sample contamination, assay interference. An ESM score is a learned inference constructed from weighted combinations of roughly 80 variables, trained on historical data that may encode past care inequities, documentation patterns, or population specific confounders. When the ESM is systematically wrong for a particular patient group, that error is invisible to the clinician at the bedside. They cannot assess it, question it, or trace it. The two situations are not structurally similar.

The analogy also sidesteps the accountability question entirely. Claude argues that knowing the population level sensitivity and PPV gives clinicians enough calibration information. But population level metrics tell a clinician nothing about why this alert fired for this patient. That gap matters most precisely when the model is wrong.

**Logical error:** False analogy. A direct biological measurement and a black box ML inference have categorically different error structures and accountability implications. Treating them as equivalent understates the responsibility gap considerably.

---

## Argument 3: Fairness Across Age Subgroups — Should Testing Be Mandatory Pre-Deployment?

### Prompt

> *"A sepsis risk model is trained on a large patient population but does not explicitly test for performance differences across age groups. Elderly patients often present with atypical sepsis physiology and may be systematically underscored. Should fairness testing across age subgroups be a mandatory requirement before deploying such a system? Give me at least two distinct actions or non-actions, with reasoning for each. Please keep your response to 300–400 words total."*

### Claude's Response

> **Action 1: Mandate subgroup fairness testing as a pre-deployment requirement.**
> Deploying a model without testing performance across age groups is not a neutral omission — it is a decision to accept unknown differential harm. Elderly patients present particular physiological challenges: blunted fever responses, atypical inflammatory markers, and baseline comorbidities that may systematically suppress risk scores. The ethical principle of justice requires that foreseeable disparate impacts be identified before deployment, not discovered retrospectively through adverse outcomes. Subgroup analysis is not technically prohibitive — if the training dataset is sufficiently large, stratified performance metrics by age band are straightforward to compute.
>
> **Non-action 2: Do not delay deployment pending perfect subgroup parity — require post-deployment monitoring instead.**
> Mandatory pre-deployment fairness testing risks becoming a barrier that keeps useful tools out of clinical practice. A model with imperfect subgroup performance may still reduce net sepsis mortality compared to no decision support at all. The more proportionate requirement is conditional deployment: the system may be released alongside a mandatory post-deployment surveillance protocol that tracks outcomes stratified by age and triggers threshold review if disparities exceed predefined tolerances.
>
> **Shared commitment:** Both recommendations reject deploying without any fairness consideration. They differ on timing and mechanism, not on principle.

> 📸 *[Insert screenshot: Argument 3 prompt and response]*

### Analysis

Action 1 is well reasoned. The framing of untested deployment as a choice to accept unknown differential harm rather than a neutral omission is the right way to put it, and the justice principle applies directly here. Elderly patients are not a marginal edge case in sepsis care, they are the most frequently affected group, and the physiological reasons their scores may be suppressed are well documented clinically.

Non-action 2 is where the reasoning becomes difficult to defend. The central argument is that a model with imperfect subgroup performance may still be better than no decision support at all, so conditional deployment with post-deployment monitoring is a proportionate middle ground. There are two problems with this.

The first is that the comparison is wrong. The alternative to deploying a fairness tested model is not the absence of any clinical decision support. Most hospitals already use structured sepsis screening protocols. The net benefit calculation only works if you assume the counterfactual is nothing, which it is not.

The second problem is more serious. Post-deployment monitoring means the evidence of differential harm is collected from real patients who were already missed. Those are not data points in a quality improvement exercise, they are people who did not receive a timely alert because the institution chose not to test for this before going live. Claude uses the language of monitoring and surveillance throughout, which makes this sound like a responsible governance process. What it actually describes is accepting a known risk of harm to a specific population and then waiting to measure how much harm occurred.

**Logical error:** The "better than nothing" framing rests on a false counterfactual and treats foreseeable harm to elderly patients as an administrative cost rather than an ethical failure. The Z3 fairness verification in this project shows the violation is formally detectable before deployment, which removes the epistemic justification for deferring the test.

---

## Argument 4: Automation Bias — Design Problem, Training Problem, or Inherent Risk?

### Prompt

> *"Studies show that when clinicians are repeatedly exposed to AI alerts, they tend to follow them without independent assessment — a phenomenon called automation bias. In a high-stakes clinical setting like sepsis detection, is automation bias primarily a training problem, a system design problem, or an inherent risk of deploying AI in clinical workflows at all? Give me at least two distinct recommended actions or non-actions, with the reasoning behind each. Please keep your response to 300–400 words total."*

### Claude's Response

> **Position 1: Automation bias is primarily a system design problem — and design can mitigate it.**
> The way an alert is presented shapes how clinicians respond to it. A binary alarm invites passive compliance; a display that shows contributing factors and explicitly prompts documentation of independent clinical reasoning invites engagement. Interface friction — requiring a clinician to actively confirm or override with a brief rationale — reduces reflexive compliance without meaningfully slowing response times. If automation bias is reliably produced by particular interface patterns, deploying those patterns unreflectively is an institutional choice, not an inevitability.
>
> **Action 2: Implement structured training, but treat it as necessary rather than sufficient.**
> Training clinicians to recognise automation bias, understand the model's known limitations, and practice deliberate override decisions is ethically mandatory. Simulation exercises where the AI is deliberately wrong build the cognitive habit of independent verification. However, training alone is insufficient. Cognitive shortcuts under time pressure and fatigue are not failures of knowledge — they are predictable features of human performance in high-load environments. Training addresses the skill gap; it does not address the conditions that make bias adaptive.
>
> **Unresolved question:** Automation bias may be partially inherent to any system where AI output is faster and less effortful than independent assessment. If true, the honest institutional response is to explicitly accept residual bias as a known risk and maintain human staffing levels sufficient to make genuine clinical reasoning possible.

> 📸 *[Insert screenshot: Argument 4 prompt and response]*

### Analysis

The two positions complement each other reasonably well. The observation that design and training address different failure modes is correct, and the acknowledgement that training cannot overcome the conditions that produce bias in the first place, fatigue, time pressure, high patient loads, reflects an honest reading of the human factors literature.

The closing paragraph is where the response loses its way. Claude raises the possibility that automation bias may be partially inherent to AI assisted clinical workflows, which is the most ethically significant point in the entire response. But having raised it, Claude does not reason through it. The paragraph offers two vague responses: accept the residual risk and maintain staffing levels. Neither is framed as a recommendation. Neither is argued for. The section reads as an observation that was added to show awareness of a harder problem without actually engaging with it. That is not epistemic humility, it is an incomplete argument.

The more substantial gap is that Claude does not engage with the virtue ethics dimension at all. Automation bias is typically framed as a cognitive shortcut problem, a clinician making a quick decision because the AI provides an easier path. But the deeper concern under virtue ethics is about what repeated reliance on AI alerts does to clinical judgment over time. A clinician who has spent three years following ESM alerts without practicing independent sepsis assessment may not simply be biased in a given moment. They may have lost the diagnostic instinct that makes meaningful override possible. That is not a training failure, it is a professional development consequence of how the system is deployed. Claude's response never addresses this.

**Logical error:** The response identifies the possibility of inherent automation bias and then declines to draw any conclusion from it. An argument that names a problem and defers resolution is not a complete piece of reasoning. The omission of virtue ethics is also notable given it was one of the three frameworks selected for this project.

---

## Summary of Identified Errors

| Argument | Claude's Recommendation | Error / Weakness |
|---|---|---|
| 1 — Threshold | Stratify by ward type | Inverts actual risk distribution; creates inequitable standard of care |
| 2 — Opacity | Opacity defensible via lab test analogy | False analogy; lab results and ML inferences have categorically different error structures |
| 3 — Fairness | Conditional deployment with post monitoring | Rests on a false counterfactual; treats foreseeable harm during monitoring as administratively acceptable |
| 4 — Automation bias | Design plus training | Names the hardest problem then declines to reason through it; omits virtue ethics entirely |

Chapters 5 and 6 each take one of these errors and argue against Claude's position using evidence from the repository.
